National Cardiogenic Shock Initiative (NCSI)

February 7, 2022 updated by: William W. O'Neill, Henry Ford Health System
This study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock. Patients are treated according to the National Cardiogenic Shock Initiative protocol, which emphasizes early identification of cardiogenic shock and rapid delivery of mechanical circulatory support based on invasive hemodynamics. All patients treated in this manner are enrolled in the National Cardiogenic Shock registry.

Study Overview

Detailed Description

Acute myocardial infarction complicated by cardiogenic shock (AMICS) is a deadly condition with a historical in-hospital survival of only 50%. To date, the only therapy proven to benefit patients in AMICS using data from randomized control trials has been early mechanical reperfusion. Accordingly, current American and European guidelines confer a class IB indication for reperfusion therapy in the setting of AMICS. Unfortunately, little progress has been made on improving survival with subsequent therapies, including intra-aortic balloon pump counter-pulsation (IABP). This lack of progress is worrisome since the incidence of AMICS appears to be increasing.

With the FDA approval of Impella (Abiomed, Danvers, MA) in AMICS, a powerful new tool has become available for hemodynamic support. Impella is a transcatheter axial flow pump, delivered percutaneous, with the ability to provide 2.5 to 4.0 liters/minute of forward flow. The device should provide sufficient forward cardiac flow to support vital organs in the majority of patients who present with AMICS. Since Impella is the only percutaneous temporary ventricular support device approved as safe and effective for use in AMICS, the use of the device has steadily grown. Unfortunately, there is little data available to providers as to the best practice patterns associated with the delivery and use of Impella in AMICS.

Using the most up-to-date research, a treatment algorithm for AMICS was developed and subsequently implemented as a quality improvement initiative throughout southeast Michigan. Patient information was gathered by each of the sites and collected in a retrospective registry. Outcomes and results were shared during quarterly meetings and concluded with a 41-patient pilot feasibility study. This initial pilot study revealed a 76% survival to discharge, a significant improvement compared to prior historical controls.

Given the promising outcomes, leaders from around the world have implemented the treatment algorithm in their local clinical practices with similar results. The investigators have therefore launched the National Cardiogenic Shock Initiative (NCSI). The aim of the NCSI is to bring together experienced centers across the nation who are experts in mechanical reperfusion therapies and have a large experience with the use of mechanical circulatory support devices to systematize care in AMICS.

Our goal is to dramatically decrease the duration patients remain in cardiogenic shock and attempt to decrease total usage and duration of vasopressors and ionotropic agents. The investigators aim to further demonstrate that rapid delivery of mechanical circulatory support will improve hemodynamics, reverse the spiraling neuro-hormonal cascade associated with cardiogenic shock, allowing clinicians to decrease use of vasopressors and inotropic agents and ultimately improve survival.

Healthcare systems that have agreed to adopt the NCSI treatment algorithm are being asked to participate in this prospective registry so that patient outcomes can be analyzed. Participating investigators will be asked to voluntarily provide data from patients completing the treatment algorithm to be included in the NCSI Registry.

Study Type

Observational

Enrollment (Actual)

406

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • UAB Hospital
    • Arkansas
      • Fayetteville, Arkansas, United States, 72703
        • Washington Regional Medical Center
      • Little Rock, Arkansas, United States, 72211
        • Arkansas Heart Hospital
      • Springdale, Arkansas, United States, 72764
        • Northwest Medical Center - Springdale
    • California
      • Loma Linda, California, United States, 92354
        • Loma Linda University Medical Center
      • Los Angeles, California, United States, 90095
        • Ronald Reagan UCLA Medical Center
      • Orange, California, United States, 92868
        • St. Joseph Hospital Orange
      • Sacramento, California, United States, 95819
        • Mercy General Hospital
      • Santa Monica, California, United States, 90404
        • UCLA Medical Center, Santa Monica
    • Colorado
      • Lakewood, Colorado, United States, 80228
        • St. Anthony Hospital
    • Connecticut
      • Stamford, Connecticut, United States, 06902
        • Stamford Hospital
    • District of Columbia
      • Washington, District of Columbia, United States, 20037
        • George Washington University Hospital
    • Florida
      • Clearwater, Florida, United States, 33756
        • Morton Plant Hospital
      • Gainesville, Florida, United States, 32605
        • North Florida Regional Medical Center
      • Hialeah, Florida, United States, 33016
        • Palmetto General Hospital
      • Jacksonville, Florida, United States, 32073
        • Orange Park Medical Center
    • Georgia
      • Gainesville, Georgia, United States, 30501
        • Northeast Georgia Medical Center
    • Illinois
      • Elmhurst, Illinois, United States, 60126
        • Elmhurst Hospital
      • Naperville, Illinois, United States, 60540
        • Edward Hospital
    • Iowa
      • Des Moines, Iowa, United States, 50314
        • Iowa Heart Center at Mercy Medical Center
    • Kansas
      • Overland Park, Kansas, United States, 66215
        • Overland Park Regional Medical Center
    • Kentucky
      • Lexington, Kentucky, United States, 40504
        • KentuckyOne Health Saint Joseph Hospital
      • Louisville, Kentucky, United States, 40202
        • KentuckyOne Health Jewish Hospital
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Beth Israel Deaconess Medical Center
      • Boston, Massachusetts, United States, 02111
        • Tufts Medical Center
      • Worcester, Massachusetts, United States, 01605
        • UMass Memorial Medical Center
    • Michigan
      • Clinton Township, Michigan, United States, 48038
        • Henry Ford Macomb Hospital
      • Detroit, Michigan, United States, 48202
        • Henry Ford Hospital
      • Detroit, Michigan, United States, 48236
        • Ascension St. John Hospital
      • Detroit, Michigan, United States, 48201
        • DMC Heart Hospital
      • Grand Rapids, Michigan, United States, 49503
        • Spectrum Health Fred and Lena Meijer Heart Center
      • Pontiac, Michigan, United States, 48341
        • St. Joseph Mercy Oakland Hospital
      • Royal Oak, Michigan, United States, 48073
        • Beaumont Hospital, Royal Oak
      • Troy, Michigan, United States, 48085
        • Beaumont Hospital, Troy
    • Mississippi
      • Tupelo, Mississippi, United States, 38801
        • North Mississippi Medical Center
    • Missouri
      • Kansas City, Missouri, United States, 64132
        • Research Medical Center
      • Saint Louis, Missouri, United States, 63110
        • SSM Health St. Louis University Hospital
    • Nebraska
      • Lincoln, Nebraska, United States, 68526
        • CHI Health Nebraska Heart
      • Omaha, Nebraska, United States, 68198
        • University of Nebraska Medical Center
    • New Jersey
      • Englewood, New Jersey, United States, 07631
        • Englewood Hospital
      • Neptune, New Jersey, United States, 07753
        • Hackensack Meridian Health Jersey Shore University Medical Center
    • New Mexico
      • Albuquerque, New Mexico, United States, 87106
        • Presbyterian Hospital
      • Farmington, New Mexico, United States, 87401
        • San Juan Regional Medical Center
    • New York
      • Buffalo, New York, United States, 14203
        • Buffalo General Medical Center
      • Buffalo, New York, United States, 14220
        • Mercy Hospital of Buffalo
      • Poughkeepsie, New York, United States, 12601
        • Vassar Brothers Medical Center
    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest Baptist Medical Center
    • Ohio
      • Cincinnati, Ohio, United States, 45219
        • The Christ Hospital
      • Kettering, Ohio, United States, 45429
        • Kettering Medical Center
    • Oregon
      • Springfield, Oregon, United States, 97477
        • PeaceHealth Sacred Heart Medical Center at Riverbend
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18103
        • Lehigh Valley Hospital
      • Darby, Pennsylvania, United States, 19023
        • Mercy Fitzgerald Hospital
      • Greensburg, Pennsylvania, United States, 15601
        • Excela Westmoreland Regional Hospital
      • Philadelphia, Pennsylvania, United States, 19140
        • Temple University Hospital
      • Pittsburgh, Pennsylvania, United States, 15212
        • Allegheny General Hospital
    • Rhode Island
      • Providence, Rhode Island, United States, 02906
        • The Miriam Hospital
      • Providence, Rhode Island, United States, 02903
        • Rhode Island Hospital
    • South Carolina
      • Greenville, South Carolina, United States, 29605
        • Greenville Memorial Hospital
      • Spartanburg, South Carolina, United States, 29303
        • Spartanburg Medical Center
    • Tennessee
      • Knoxville, Tennessee, United States, 37920
        • University of Tennessee Medical Center
      • Knoxville, Tennessee, United States, 37934
        • Turkey Creek Medical Center
      • Knoxville, Tennessee, United States, 37916
        • Fort Sanders Regional Medical Center
      • Knoxville, Tennessee, United States, 37849
        • North Knoxville Medical Center
      • Knoxville, Tennessee, United States, 37917
        • Physicians Regional Medical Center
      • Knoxville, Tennessee, United States, 37923
        • Parkwest Regional Medical Center
      • Memphis, Tennessee, United States, 38104
        • Methodist University Hospital
      • Nashville, Tennessee, United States, 37203
        • TriStar Centennial Medical center
      • Oak Ridge, Tennessee, United States, 37830
        • Methodist Medical Center
    • Texas
      • Austin, Texas, United States, 78756
        • Heart Hospital of Austin
      • Dallas, Texas, United States, 75231
        • Texas Health Presbyterian Hospital Dallas
      • San Antonio, Texas, United States, 78234
        • Brooke Army Medical Center
      • San Antonio, Texas, United States, 78229
        • Methodist Hospital
    • Virginia
      • Charlottesville, Virginia, United States, 22903
        • UVA University Hospital
      • Falls Church, Virginia, United States, 22042
        • Inova Fairfax Hospital
      • Roanoke, Virginia, United States, 24014
        • Carilion Roanoke Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients presenting with acute myocardial infarction and cardiogenic shock treated with mechanical circulatory support.

Description

Registry Inclusion Criteria:

  1. Symptoms of acute myocardial infarction (AMI) with ECG and/or biomarker evidence of S-T elevation myocardial infarction (STEMI) or non-S-T elevation myocardial infarction (NSTEMI)
  2. Cardiogenic shock is defined as the presence of at least two of the following:

    1. Hypotension (systolic blood pressure ≤90 mm Hg, or inotropes/vasopressors to maintain systolic blood pressure ≥90 mmHg)
    2. Signs of end organ hypoperfusion (cool extremities, oliguria or anuria, or elevated lactate levels)
    3. Hemodynamic criteria represented by a cardiac index of <2.2 L/min/m2 or a cardiac power output ≤0.6 watts.
  3. Patient is supported with an Impella
  4. Patient undergoes PCI

Registry Exclusion Criteria:

  1. Evidence of Anoxic Brain Injury
  2. Unwitnessed out of hospital cardiac arrest or any cardiac arrest in which return of spontaneous circulation (ROSC) is not achieved within 30 minutes
  3. IABP placed prior to Impella
  4. Septic, anaphylactic, hemorrhagic, and neurologic causes of shock
  5. Non-ischemic causes of shock/hypotension (pulmonary embolism, pneumothorax, myocarditis, tamponade, etc.)
  6. Active bleeding for which mechanical circulatory support is contraindicated
  7. Recent major surgery for which mechanical circulatory support is contraindicated
  8. Mechanical complications of AMI (acute ventricular septal defect (VSD) or acute papillary muscle rupture)
  9. Known left ventricular thrombus for which mechanical circulatory support is contraindicated
  10. Mechanical aortic prosthetic valve
  11. Contraindication to intravenous systemic anticoagulation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival to discharge from hospital
Time Frame: Hospital discharge (average= 11 days)
All cause mortality at hospital discharge.
Hospital discharge (average= 11 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 Day Mortality
Time Frame: 30 days
All cause mortality at 30 days post-discharge.
30 days
1 Year Mortality
Time Frame: 1 year
All cause mortality at 1 year post-discharge
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of MCS Pre-PCI
Time Frame: At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Number of patients who receive mechanical circulatory support (MCS) pre-PCI (percutaneous coronary intervention).
At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Door to Support Time < 90 Minutes
Time Frame: At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Time from patient presentation at hospital to time that MCS (mechanical circulatory support) was started.
At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Establish TIMI III Flow
Time Frame: At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Establishment of TIMI III (thrombolysis in myocardial infarction) coronary blood flow during index PCI (percutaneous coronary intervention) in culprit lesions.
At index Cath Lab procedure/PCI (percutaneous coronary intervention)
Wean off Vasopressors & Inotropes
Time Frame: At index PCI (percutaneous coronary intervention), 12-hours post-PCI, 24-hours post-PCI
Ability to wean off vasopressor & inotropic medication use in patients being treated with early MCS (mechanical circulatory support) during treatment for AMICS (acute myocardial infarction with cardiogenic shock).
At index PCI (percutaneous coronary intervention), 12-hours post-PCI, 24-hours post-PCI
Maintain CPO >0.6 Watts
Time Frame: At index PCI (percutaneous coronary intervention), 12-hours post-PCI, 24-hours post-PCI
Ability to maintain a cardiac power output (CPO) measurement of > 0.6 watts.
At index PCI (percutaneous coronary intervention), 12-hours post-PCI, 24-hours post-PCI

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Babar Basir, DO, Henry Ford Health System

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2016

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

August 17, 2018

First Submitted That Met QC Criteria

September 17, 2018

First Posted (Actual)

September 19, 2018

Study Record Updates

Last Update Posted (Actual)

February 9, 2022

Last Update Submitted That Met QC Criteria

February 7, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Myocardial Infarction

3
Subscribe